Campylobacter jejuni subsp. jejuni (Jones et al.) Veron and Chatelain (ATCC® BAA-527)

Strain Designations: HB95-29  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations HB95-29
Application
Emerging infectious disease research
Enteric Research
Isolation
Patient with Guillain-Barre Syndrome, China
By I Nachamkin and CY Li, 1995
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype HS:19
Product Format freeze-dried
Preceptrol® no
Type Strain no
Antigenic Properties Serotype HS:19
Medium ATCC® Medium 1115: Brucella albimi broth
ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions
Temperature: 37°C
Atmosphere: Microaerophilic (10% CO2, 3-5% O2)
Name of Depositor I Nachamkin
Isolation
Patient with Guillain-Barre Syndrome, China
By I Nachamkin and CY Li, 1995
Year of Origin 1995
References

Nachamkin I, et al. Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barre syndrome and gastroenteritis.. J. Infect. Dis. 184: 221-226, 2001. PubMed: 11400077